Guardant Health, Inc.
GH
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$93.83
Price+2.94%
$2.68
1Y
Price
Market Cap
$12.308b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-42.3%
EBITDA Margin-45.7%
Net Profit Margin-14.9%
Free Cash Flow Margin-42.3%
EBITDA Margin-45.7%
Net Profit Margin-14.9%
Free Cash Flow MarginRevenue
$982.021m
+32.9%
1y CAGR+29.8%
3y CAGR+27.4%
5y CAGREarnings
-$416.277m
+4.6%
1y CAGR+13.4%
3y CAGR-5.2%
5y CAGREPS
-$3.32
+7.0%
1y CAGR+19.0%
3y CAGR-2.9%
5y CAGRBook Value
-$99.307m
$2.014b
Assets$2.113b
Liabilities$1.682b
DebtDebt to Assets
83.6%
-4.5x
Debt to EBITDAFree Cash Flow
-$233.066m
+19.7%
1y CAGR+16.9%
3y CAGR+3.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company